BioWorld

Feb. 16, 2007

View Archived Issues

Biogen Idec Increases Profits But Misses 4Q EPS Estimates

Biogen Idec Inc. turned in adjusted earnings per share of 53 cents for the quarter ended Dec. 31, two pennies lower than consensus estimates on revenue that also came in weaker than expected. (BioWorld Today) Read More

NovaBay Seeks Dual Listing, Aims For $23M In IPO Filing

Read More

Developmental Master Molecule Adds Palate Formation To Tasks

Read More

Cepheid Buys Diagnostics Firm, Boosts Portfolio of Assay Tools

Read More

Holiday Notice

Read More

Other News To Note

Read More

Clinic Roundup

Read More